ACXP
Acurx Pharmaceuticals Inc

1,904
Loading...
Loading...
Acurx Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company, which engages in developing new antibiotics for infections caused by bacteria listed as priority pathogens. Its approach is to develop antibiotic candidates that target the DNA polymerase IIIC enzyme. Its research and development pipeline includes early-stage antibiotic candidates that target other Gram-positive bacteria, including Methicillin-Resistant Staphylococcus aureus, Vancomycin-Resistant Enterococcus and Penicillin-Resistant Streptococcus pneumoniae. The company was founded by David P. Luci, Robert G. Shawah and Robert J. DeLuccia in July 2017 and is headquartered in New York, NY.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
4

Frequently Asked Questions

What is Market Cap of Acurx Pharmaceuticals Inc?
What is the 52-week high for Acurx Pharmaceuticals Inc?
What is the 52-week low for Acurx Pharmaceuticals Inc?
What is Acurx Pharmaceuticals Inc stock price today?
What was Acurx Pharmaceuticals Inc stock price yesterday?
What is the PE ratio of Acurx Pharmaceuticals Inc?
What is the Price-to-Book ratio of Acurx Pharmaceuticals Inc?
What is the 50-day moving average of Acurx Pharmaceuticals Inc?
How many employess does Acurx Pharmaceuticals Inc has?

Latest ACXP News

View

Advertisement. Remove ads.

Advertisement. Remove ads.